The importance of erythroblast enumeration in myeloid neoplasia

Ann Hematol. 2017 Feb;96(2):329-330. doi: 10.1007/s00277-016-2862-0. Epub 2016 Oct 23.

Authors

Amer M Zeidan¹, Mina Xu², David P Steensma³

Affiliations

¹ Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, 333 Cedar Street, PO. Box 208028, New Haven, CT, 06520-8028, USA. amer.zeidan@yale.edu.
² Department of Pathology, Yale University, New Haven, CT, USA.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

PMID: 27771743
DOI: 10.1007/s00277-016-2862-0

No abstract available

Keywords: Blasts; Myelodysplastic syndromes; Prognostication.

Publication types

Letter

MeSH terms

Erythroblasts / metabolism*
Erythrocyte Count / methods*
Humans
Myelodysplastic Syndromes / blood*
Myelodysplastic Syndromes / diagnosis